Irreversible G2-M arrest and cytoskeletal reorganization induced by cytotoxic nucleoside analogues

Cancer Research

Volumn 58, Issue 17, 1998, Pages 3855-3865

  Halloran, Patrick J ^a   Fenton, Robert G ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC AGENT; GANCICLOVIR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; NUCLEOSIDE ANALOG; ANTINEOPLASTIC AGENT; CYCLIN B; PROTAMINE KINASE;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL CYCLE; CONTROLLED STUDY; CYTOSKELETON; DNA DAMAGE; DRUG CYTOTOXICITY; FEMALE; HERPES SIMPLEX VIRUS; INTRAPERITONEAL DRUG ADMINISTRATION; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL CYCLE G2 PHASE; DRUG ANTAGONISM; DRUG EFFECT; MITOSIS;

ANIMALS; ANTINEOPLASTIC AGENTS; CYCLIN B; CYTOSKELETON; DNA DAMAGE; FEMALE; G2 PHASE; GANCICLOVIR; LOVASTATIN; MICE; MICE, INBRED C57BL; MITOSIS; PROTAMINE KINASE; TUMOR CELLS, CULTURED;

EID: 0032148384     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Nasmyth, K. Viewpoint: putting the cell cycle in order. Science (Washington DC), 274: 1643-1645, 1996.
2. Elledge, S. J. Cell cycle checkpoints: preventing an identity crisis. Science (Washington DC), 274: 1664-1672, 1996.
3. Sherr, C. J. Cancer cell cycles. Science (Washington DC), 274: 1672-1677, 1996.
4. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K., and Elledge, S. J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75: 805-816, 1993.
5. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
6. Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. p21 is a universal inhibitor of cyclin kinases. Nature (Lond.), 366: 701-704, 1993.
7. Reid, R., Mar, E-C., Huang, E-S., and Topal, M. D. Insertion and extension of acyclic, dideoxy, and ara nucleotides by Herpesviridae, human α and human β polymerases. J. Biol. Chem., 263: 3898-3904, 1988.
8. Moolten, F. L. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res., 46: 5276-5281, 1986.
9. Culver, K. W., Ram, Z., Walbridge, S., Ishii, H., Oldfield, E. H., and Blaese, R. M. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science (Washington DC), 256: 1550-1552, 1992.
10. Freeman, S. M., Whartenby, K. A., Freeman, J. L., Abboud, C. N., and Marrogi, A. J. In situ use of suicide genes for cancer gene therapy. Semin. Oncol., 23: 31-45, 1996.
11. Siders, W. M., Halloran, P. J., and Fenton, R. G. Melanoma-specific cytotoxicity induced by a tyrosinase promoter-enhancer/HSV-tk adenovirus. Cancer Gene Ther., in press, 1998.
12. Talanian, R., Quinlan, C., Trautz, S., Hacken, M., Mankovich, J., Banach, D., Ghayur, T., Brady, K. D., and Wong, W. W. Substrate specificities of caspase family proteases. J. Biol. Chem., 272: 9677-9682, 1997.
13. Ridley, A. J. The GTP-binding protein Rho. Int. J. Biochem. Cell Biol., 29: 1225-1229, 1997.
14. Olson, M. F., Ashworth, A., and Hall, A. An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science (Washington DC), 269: 1270-1272, 1995.
15. Fenton, R. G., Kung, H. F., Longo, D. L., and Smith, M. R. Regulation of intracellular actin polymerization by prenylated cellular proteins. J. Cell Biol., 117: 347-356, 1992.
16. Freeman, S. M., Abboud, C. N., Whartenby, K. A., Packman, C. H., Koeplin, D. S., Moolten, F. L., and Abraham, G. N. The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res., 53: 5274-5283, 1993.
17. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell, 88: 323-331, 1997.
18. Nurse, P. Universal control mechanism regulating onset of M-phase. Nature (Lond.), 344: 503-508, 1990.
19. King, R. W., Jackson, P. K., and Kirschner, M. W. Mitosis in transition. Cell, 79: 563-571, 1994.
20. Dilber, M. S., Abedi, M. R., Christensson, B., Bjorkstrand, B., Kidder, G. M., Naus, C. C., Gahrton, G., and Smith, C. I. Gap junctions promote the bystander effect of Herpes Simplex Virus thymidine kinase in vivo. Cancer Res., 57: 1523-1528, 1997.
21. Hamel, W., Magnelli, L., Chiarugi, V. P., and Isreal, M. A. Herpes Simplex Virus thymidine kinase/ganciclovir-mediated apoptotic death of bystander cells. Cancer Res., 56: 2697-2702, 1996.
22. Nobes, C. D., and Hall, A. Rho, Rac, and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell, 81: 53-62, 1995.
23. Hall, A. Rho GTPases and the actin cytoskeleton. Science (Washington DC), 279: 509-514, 1998.
24. Mueller, P. R., Coleman, T. R., Kumagai, A., and Dunphy, W. G. Myt1: a membrane-associated inhibitory kinase that phosphorylates Cdc2 on both threonine-14 and tyrosine-15. Science (Washington DC), 270: 86-90, 1995.
25. Rhind, N., Furnari, B., and Russell, P. Cdc2 tyrosine phosphorylation is required for the DNA damage checkpoint in fission yeast. Genes Dev., 11: 504-511, 1997.
26. Jin, P., Gu, Y., and Morgan, D. O. Role of inhibitory Cdc2 phosphorylation in radiation-induced G2 arrest in human cells. J. Cell Biol., 134: 963-970, 1996.
27. Sanchez, Y., Wong, C., Thoma, R. S., Richman, R., Wu, Z., Piwnica-Worms, H., and Elledge, S. J. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science (Washington DC), 277: 1497-1501, 1997.
28. Furnari, B., Rhind, N., and Russell, P. Cdc25 mitotic inducer targeted by Chk1 DNA damage checkpoint kinase. Science (Washington DC), 277: 1495-1497, 1997.
29. Peng, C-Y., Graves, P. R., Thoma, R. S., Wu, Z., Shaw, A. S., and Piwnica-Worms, H. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science (Washington DC), 277: 1501-1505, 1997.
30. Muslin, A. J., Tanner, J. W., Allen, P. M., and Shaw, A. S. Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell, 84: 889-897, 1996.
31. Lehmann, A. R., and Carr, A. M. The ataxia-telangiectasia gene: a link between checkpoint controls, neurodegeneration and cancer. Trends Genet., 11: 375-377, 1995.
32. Cimprich, K. A., Shin, T. B., Keith, C. T., and Schreiber, S. L. cDNA cloning and gene mapping of a candidate human cell cycle checkpoint protein. Proc. Natl. Acad. Sci. USA, 93: 2850-2855, 1996.
33. Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, A. J. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell, 71: 587-597, 1992.
34. Lu, X., and Lane, D. P. Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes? Cell, 75: 765-778, 1993.
35. 2-M progression. Mol. Cell, 1: 3-11, 1997.
36. Deng, C., Zhang, P., Harper, J. W., Elledge, S. J., and Leder, P. Mice lacking p21Cip/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell, 82: 675-684, 1995.
37. Brugarolas, J., Chandrasekaran, C., Gordon, J. I., Beach, D., Jacks, T., and Hannon, G. J. Radiation induced cell cycle arrest compromised by p21 deficiency. Nature (Lond.), 377: 552-557, 1995.
38. Terada, Y., Tatsuka, M., Shigeki, J., and Okayama, H. Requirement for tyrosine phosphorylation of Cdk4 in G1 arrest induced by ultraviolet irradiation. Nature (Lond.), 376: 358-362, 1995.
39. Waldman, T., Zhang, Y., Dillehay, L., Yu, J., Kinzler, K., Vogelstein, B., and Williams, J. Cell-cycle arrest versus cell death in cancer therapy. Nat. Med., 3: 1034-1036, 1997.
40. Fram, R. J., Egan, E. M., and Kufe, D. W. Accumulation of leukemic cell DNA strand breaks with adriamycin and 1-β-D-arabinofuranosylcytosine. Leuk. Res., 7: 243-249, 1983.